Astrana Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	25.65	13.98	38.68	41.09	35.96	34.85
Other Revenue	2,871	2,021	1,348	1,103	737.96	652.33
Revenue	2,896	2,035	1,387	1,144	773.92	687.18
Revenue Growth (YoY)	68.17%	46.72%	21.19%	47.84%	12.62%	22.57%
Cost of Revenue	2,599	1,763	1,172	944.69	596.14	539.21
Gross Profit	296.97	271.39	214.96	199.48	177.77	147.97
Selling, General & Admin	178.24	154.11	112.6	77.67	62.08	49.12
Operating Expenses	215.72	182.04	130.35	95.21	79.59	67.47
Operating Income	81.25	89.35	84.61	104.27	98.18	80.5
Interest Expense	-40.48	-33.1	-16.1	-7.92	-5.39	-9.5
Interest & Investment Income	11.39	14.51	14.21	1.98	1.57	2.81
Earnings From Equity Investments	2.1	4.45	5.58	5.62	-4.31	3.69
Other Non Operating Income (Expenses)	-3.13	4.88	4.88	2.57	3.92	1.08
EBT Excluding Unusual Items	51.13	80.09	93.17	106.52	93.97	78.59
Gain (Loss) on Sale of Investments	-0.52	0.73	-3.34	-19	-18.98	99.84
Other Unusual Items	-	-	-	-0.9	2.75	-
Pretax Income	30.21	80.82	89.84	86.62	77.75	178.43
Income Tax Expense	20.47	30.89	31.99	40.88	31.69	56.34
Earnings From Continuing Operations	9.74	49.93	57.85	45.74	46.06	122.08
Minority Interest in Earnings	-0.2	-6.78	2.87	-0.57	22.87	-84.4
Net Income	9.54	43.15	60.72	45.17	68.92	37.69
Net Income to Common	9.54	43.15	60.72	45.17	68.92	37.69
Net Income Growth	-84.73%	-28.93%	34.42%	-34.46%	82.88%	166.99%
Shares Outstanding (Basic)	49	48	47	45	44	37
Shares Outstanding (Diluted)	49	48	47	46	45	37
Shares Change (YoY)	2.59%	2.20%	2.94%	0.44%	21.24%	2.87%
EPS (Basic)	0.20	0.91	1.30	1.00	1.57	1.03
EPS (Diluted)	0.20	0.90	1.29	0.99	1.52	1.01
EPS Growth	-84.99%	-30.23%	30.30%	-34.87%	50.50%	158.97%
Free Cash Flow	96.96	44.17	39.7	59.19	51.11	45
Free Cash Flow Per Share	1.98	0.92	0.85	1.30	1.13	1.20
Gross Margin	10.25%	13.34%	15.50%	17.43%	22.97%	21.53%
Operating Margin	2.80%	4.39%	6.10%	9.11%	12.69%	11.71%
Profit Margin	0.33%	2.12%	4.38%	3.95%	8.91%	5.48%
Free Cash Flow Margin	3.35%	2.17%	2.86%	5.17%	6.60%	6.55%
EBITDA	118.72	117.28	102.36	121.81	115.7	98.85
EBITDA Margin	4.10%	5.76%	7.38%	10.65%	14.95%	14.38%
D&A For EBITDA	37.47	27.93	17.75	17.54	17.52	18.35
EBIT	81.25	89.35	84.61	104.27	98.18	80.5
EBIT Margin	2.80%	4.39%	6.10%	9.11%	12.69%	11.71%
Effective Tax Rate	67.76%	38.22%	35.61%	47.19%	40.76%	31.58%
Revenue as Reported	2,896	2,035	1,387	1,144	773.92	687.18

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q